Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
April 25, 2024 4:49 AM EDTSanofi (NASDAQ: SNY) reported Q1 EPS of EUR1.78, EUR0.85 better than the analyst estimate of EUR0.93. Revenue for the quarter came in at EUR10.46 billion versus the consensus estimate of EUR11.47 billion.
GUIDANCE
Sanofi expects 2024 business EPS to remain roughly... More
